Discover 2,551 paid clinical trials in Fairfield, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,551
Active & Responsive
Neonatal White Matter Injury Trial (WRAP)
for
White Matter Injury, Brain Injury, Fetus and Neonate,
Location: San Francisco CA
Sponsor: Bridget LaMonica Ostrem, M.D., Ph.D.
Sex: All
Age: 0
Code: NCT07688746
Phase 1, Recruiting
Active & Responsive
Zanzalintinib for Metastatic Clear Cell Renal Cell Carcinoma With Bone Metastases
for
Clear Cell Renal Cell Cancer (ccRCC),
Location: San Francisco CA
Sponsor: Kelly Fitzgerald, MD
Sex: All
Age: 18+
Code: NCT07043608
Phase 2, Recruiting
Active & Responsive
A Substudy of Investigational Agents in Programmed Cell Death-1/Ligand 1 (PD-1/L1) Refractory Locally Advanced or Metastatic Urothelial Carcinoma (mUC) (MK-3475-04A)
for
Urothelial Carcinoma
Location: San Francisco CA, Orange CA, Salt Lake City UT,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT05562830
Phase 1, Phase 2, Recruiting
Active & Responsive
A Safety and Efficacy Study of hu14 in High-Risk Neuroblastoma Patients
for
High-Risk Neuroblastoma
Location: San Francisco CA, Aurora CO, Dallas TX, Minneapolis MN,
Sponsor: Renaissance Pharma Ltd.
Sex: All
Age: 1 - 18
Code: NCT07549321
Phase 2, Phase 3, Recruiting
Active & Responsive
Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus
for
Type 1 Diabetes Mellitus
Location: San Francisco CA, Salt Lake City UT, Seattle WA,
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Sex: All
Age: 8 - 45
Code: NCT07142252
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Dose Escalation and Expansion Study to Evaluate the Safety, PK, PD and Efficacy of ZE46-0134 in Adults With FLT3 Mutated or Spliceosome Mutated Relapsed or Refractory Acute Myeloid Leukemia
for
AML With Gene Mutations
Location: San Francisco CA, Los Angeles CA, Portland OR,
Sponsor: Lomond Therapeutics Holdings, Inc.
Sex: All
Age: 18+
Code: NCT06366789
Phase 1, Recruiting
Active & Responsive
Teen and Adult Tic TMS Study
for
Tic Disorder
Location: San Francisco CA
Sponsor: University of California, San Francisco
Sex: All
Age: 15 - 35
Code: NCT07839377
Recruiting
Active & Responsive
CASCADE 2002: PROTECT Study, "PRObiotics to TrEat Anal preCancer Trial
for
HSIL, High Grade Squamous Intraepithelial Lesion,
Location: San Francisco CA
Sponsor: University of California, San Francisco
Sex: All
Age: 21+
Code: NCT06949800
Phase 2, Recruiting
Active & Responsive
ctDNA-Guided Therapy for Relapsed/Refractory Hodgkin Lymphoma
A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis
for
Lupus Nephritis, Systemic Lupus Erythematosus,
Location: San Francisco CA, Beverly Hills CA, Fullerton CA,
Sponsor: Fate Therapeutics
Sex: All
Age: 12 - 70
Code: NCT07570862
Phase 2, Recruiting
Active & Responsive
Prehab and Creatine/Whey Supplementation in Frailty Among Patients With Cirrhosis
for
Cirrhosis, Frailty, Sarcopenia
Location: San Francisco CA
Sponsor: University of California, San Francisco
Sex: All
Age: 18+
Code: NCT07029243
Recruiting
Active & Responsive
PVI Alone Versus PVI Plus PWI and SVCI With PFA
for
Persistent Atrial Fibrillation
Location: San Francisco CA
Sponsor: Edward Gerstenfeld, MD
Sex: All
Age: 18+
Code: NCT07405359
Recruiting
Active & Responsive
Safety and Efficacy of Adjunct Therapies in Adults With Type 1 Diabetes: Multicenter, Registry Study
for
Type 1 Diabetes
Location: San Francisco CA, Newport Beach CA, Omaha NE,
Sponsor: Indiana University
Sex: All
Age: 18+
Code: NCT07676565
Recruiting
Active & Responsive
A Gaucher Disease Gene Therapy Trial With FLT201
for
Gaucher Disease Type 1
Location: San Francisco CA, Los Angeles CA, Aurora CO, Calgary,
Sponsor: Spur Therapeutics
Sex: All
Age: 18+
Code: NCT07223944
Phase 3, Recruiting
Active & Responsive
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
for
Glioma, Astrocytoma, Grade IV, IDH1-mutant Glioma,
Location: San Francisco CA, Palo Alto CA, Los Angeles CA,
Sponsor: Nuvation Bio Inc.
Sex: All
Age: 18+
Code: NCT05303519
Phase 3, Recruiting
Active & Responsive
Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer
for
Endometrial Cancer
Location: San Francisco CA, Eugene OR, La Jolla CA, Portland OR,
Sponsor: Faeth Therapeutics
Sex: Female
Age: 18+
Code: NCT06463028
Phase 2, Recruiting
Active & Responsive
A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation (The ReInspire Study)
for
PIK3CA-Related Overgrowth Spectrum (PROS),
Location: San Francisco CA, Palo Alto CA, Los Angeles CA,
Sponsor: Relay Therapeutics, Inc.
Sex: All
Age: 2+
Code: NCT06789913
Phase 2, Recruiting
Active & Responsive
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies